20 Stocks Moving in Tuesday's Pre-Market Session

Gainers

• Aptorum Group Limited APM shares rose 94.4% to $3.15 in pre-market trading after gaining around 10% on Monday. The FDA recently granted Orphan Drug Designation to Aptorum Group’s SACT-1, a repurposed small molecule compound for Neuroblastoma.
• Esports Entertainment Group, Inc. GMBL rose 16.1% to $3.17 in pre-market trading. Esports Entertainment, on Monday, received an order approving a transactional waiver from the Director of the New Jersey Division of Gaming Enforcement, permitting the company to begin accepting bets in the state.
• BT Brands, Inc. BTBD rose 8.1% to $3.35 in pre-market trading after climbing around 28% on Monday.
• Kintara Therapeutics, Inc. KTRA rose 8% to $0.3995 in pre-market trading after declining more than 6% on Monday.
• Innate Pharma S.A. IPHA shares rose 8% to $4.01 in pre-market trading following a 10% drop on Monday.
• Logitech International S.A. LOGI rose 7.5% to $80.01 in pre-market trading as the company posted upbeat quarterly results and raised fiscal 2022 forecast.
• WISeKey International Holding AG WKEY shares rose 7.2% to $3.69 in pre-market trading.
• Telefonaktiebolaget LM Ericsson ERIC rose 7% to $11.66 in pre-market trading after reporting upbeat core earnings for its fourth quarter.
• Zosano Pharma Corporation ZSAN rose 6.4% to $0.5080 in pre-market trading. Zosano Pharma, on January 18, resubmitted its M207 (Zolmitriptan Transdermal Microneedle System) 505(B)(2) NDA to the FDA.
• International Business Machines Corporation IBM rose 2.8% to $132.40 in pre-market trading after the company reported better-than-expected fourth-quarter EPS and sales results.

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these penny stocks insiders are buying

Losers

• Vaxxinity, Inc. VAXX shares fell 13.4% to $7.44 in pre-market trading after gaining more than 5% on Monday. Vaxxinity recently said the first Parkinson's disease patient was dosed in Part B of a Phase 1 clinical trial of UB-312.
• Pulmatrix, Inc. PULM shares fell 10.5% to $0.35 in pre-market trading. Pulmatrix, last month, announced a $6.75 million registered direct offering.
• Blue Star Foods Corp. BSFC shares fell 10.5% to $3.55 in pre-market trading after gaining around 5% on Monday.
• Brickell Biotech, Inc. BBI shares fell 8.5% to $0.2116 in pre-market trading. HC Wainwright & Co recently initiated coverage on the stock with a Buy rating and $2 price target.
• NeuroBo Pharmaceuticals, Inc. NRBO fell 8.5% to $1.07 in pre-market trading after gaining around 5% on Monday.
• TCR2 Therapeutics Inc. TCRR fell 7.3% to $3.30 in pre-market trading. Goldman Sachs, last week, downgraded TCR2 Therapeutics from Buy to Neutral and lowered the price target from $28 to $5.
• Pintec Technology Holdings Limited PT fell 6.4% to $0.6161 in pre-market trading after dipping more than 52% on Monday.
• Reviva Pharmaceuticals Holdings, Inc. RVPH shares fell 6.4% to $1.76 in pre-market trading. HC Wainwright & Co, on Monday, initiated coverage on Reviva Pharmaceuticals with a Buy rating and announced a price target of $10.
• Ocugen, Inc. OCGN fell 5.4% to $3.14 in pre-market trading. Ocugen, on Monday, named Nirdosh Jagota, Ph.D., as Senior Vice President (SVP), Regulatory Affairs, compliance and safety.
• Society Pass Incorporated SOPA fell 5.3% to $5.00 in pre-market trading.